Press release
What Factors are Affecting Growth and Demand of Atopic Dermatitis Market | Trends and Forecast till 2027 by Fact.MR
Dermatological disorders are increasing with each passing day. The World Health Organization estimates that more than 900 million people are suffering from skin ailments since 2017.Click here to Get Complete Synopsis of the Report – https://www.factmr.com/report/4603/atopic-dermatitis-market
Atopic dermatitis accounts for a major chunk of these illnesses, with more than 300 million people, mostly children, affected by it. Based on the aforementioned trends, the global atopic dermatitis drugs is expected to register astounding growth of 24% between 2020 and 2027.
Research and development in manufacturing novel drugs, rising demand for biologics and product approvals are other factors augmenting market growth. On this premise, the atopic dermatitis market is poised to surpass a valuation of US$ 19 Bn by the end of the forecast period.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4603
Key Takeaways of Global Atopic Dermatitis Drugs Market Study
• Biologics Drugs is the leading segment by drug class. Projected CAGR for the same is pegged at a staggering CAGR of 32.1% during the forecast period. New product launches and increased adoption of Biologics drugs are key factors driving the growth of the segment.
• PDE4 Inhibitors closely follow the biologics drugs segment, registering a whopping CAGR of 31.1%. Increased affordability of treatment and intensive research and development are expected to drive the growth of PDE4 Inhibitors.
• Retail Pharmacies are expected to account for three-fourth of the market share for atopic dermatitis drugs. Increased number of retail pharmacies, easy availability of therapeutic drugs and convenience are some contributing factors.
For critical insights on this market, request for methodology here - https://www.factmr.com/connectus/sample?flag=RM&rep_id=4603
• North America shall retain its dominance in the atopic dermatitis drugs market. Adoption of advanced biologics drugs, adequate reimbursement coverage for pharmaceutical companies and greater market penetration of new players are some major growth stimulators. The region is set to expand at a CAGR of 27% during the forecast period.
• Europe is the second most attractive market, accounting for around one-third of the global atopic dermatitis drugs market. This is due to increased awareness about the disease, favorable medical reimbursement policies and well-established healthcare facilities.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4603
Global Atopic Dermatitis Drugs Market Segmentation
Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.
Drug Class
• Corticosteroids
• PDE4 Inhibitors
• Biologics
• Skin Barrier Emollients
• CNI Immunosuppressants
• Others
Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
Key Regions
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/05/30/1859437/0/en/MRI-Guided-Radiation-Therapy-Systems-Touted-as-Future-of-Cancer-Treatment-finds-Fact-MR-study.html
Development of Novel Drugs to Determine Market Competitiveness
Investments in development of novel pipeline drugs is expected to shape the global atopic dermatitis drugs market competitiveness. An example for this is the development of the biologics drug DUPIXNET ® by Sanofi Genzyme, which cures skin lesions and reduces itching. It does so by inhibiting secretions of interleukin-4 (IL-4) and interleukin-13 (IL-13) protein strains, responsible for type 2 skin inflammation. Likewise, Eucrisa (crisaborole), developed by Pfizer, Inc., consists of PDE4 Inhibitors to treat skin ailments like Eczema. It works by controlling the over-reactive parts of the PDE4 enzyme within skin cells to prevent inflammation.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Content Source: https://www.factmr.com/media-release/1373/global-atopic-dermatitis-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release What Factors are Affecting Growth and Demand of Atopic Dermatitis Market | Trends and Forecast till 2027 by Fact.MR here
News-ID: 2307174 • Views: …
More Releases from Fact.MR
E-Beam Wafer Inspection System Market is Expected to Progress at a CAGR of 18.3% …
The global e-beam wafer inspection system market is projected to increase from USD 862.5 million in 2025 to USD 4,630.3 million by 2035, with a CAGR of 18.3% during the forecast period. Growth is driven by rising demand for high-quality semiconductor wafers fueled by advanced electronic devices and emerging technologies.
E-beam wafer inspection systems are ideal for their ability to provide ultra-high-resolution nanoscale defect detection, down to 1-2 nanometers, enabling precise…
Fire Pits Market is Poised to Grow at a CAGR of 3.5% to Reach US$ 217.1 Million …
The global fire pits market is forecast to reach USD 217.1 million by 2035, up from USD 153.9 million in 2025. During the forecast period, the industry is projected to register a CAGR of 3.5%.
Increasing outdoor living investments as homeowners seek better leisure spaces are driving the fire pits market. Consumers are increasingly incorporating fire pits into gardens, patios, and backyard spaces to create inviting, cozy environments for social gatherings…
Drone Battery Industry Analysis in Europe is Predicted to Reach US$ 4.31 Billion …
According to the latest study published by Fact.MR, demand for drone batteries in Europe is estimated at a market value of US$ 2.03 billion in 2024. The European market is projected to expand at a CAGR of 7.8% and reach US$ 4.31 billion by the end of 2034.
Increasing demand for drones in several use cases, including photography, construction, agriculture, delivery, and surveillance, is set to drive the sales of long-lasting…
North America Cosmetic Dropper Market to Reach 4.1% CAGR by 2035, Driven by Prem …
The global cosmetic dropper market is poised for significant growth, driven by evolving consumer preferences and advancements in packaging technologies. The market is projected to expand from USD 98.6 million in 2025 to USD 185.1 million by 2035, registering a compound annual growth rate (CAGR) of 6.5% during this period. This growth reflects an increasing demand for cosmetic products that combine functionality, aesthetics, and convenience.
For More Insights into the Market,…
More Releases for PDE4
PDE4 Inhibitors Market Growth Accelerates Amid FDA Approvals, Pipeline Expansion …
DelveInsight's PDE4 Inhibitor Market Report Reveals Significant Growth Through 2034, Led by Arcutis Biotherapeutics, Pfizer, Shionogi, Palisade Bio, UNION Therapeutics, Amgen, and Chiesi Farmaceutici with Key Assets Including ZORYVE, EUCRISA, OTEZLA, Zatolmilast, and PALI-2108 Across Multiple Inflammatory Conditions.
DelveInsight Business Research's extensive market analysis titled "Phosphodiesterase-4 (PDE4) Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034 [https://www.delveinsight.com/report-store/phosphodiesterase-4-pde4-inhibitor-market-forecast?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]," provides a comprehensive insights into this rapidly evolving therapeutic class across…
Phosphodiesterase-4 (PDE4) Inhibitor Market: Projected Significant Growth During …
(Albany, USA) The Phosphodiesterase-4 (PDE4) Inhibitor market size is anticipated to increase in the study period due to a direct consequence of an increase in R&D activity in the 7MM. Additionally, the competitive landscape is relatively sparse and the regulatory pathway for approval will likely involve extensive clinical trials to demonstrate safety and efficacy.
DelveInsight's Phosphodiesterase-4 (PDE4) Inhibitor Market Insights report includes a comprehensive understanding of current treatment practices, emerging Phosphodiesterase-4…
Phosphodiesterase-4 (PDE4) Inhibitor Market: Anticipated Surge in Growth Through …
(Albany, USA) The Phosphodiesterase-4 (PDE4) Inhibitor market size is anticipated to increase in the study period due to a direct consequence of an increase in R&D activity in the 7MM. Additionally, the competitive landscape is relatively sparse and the regulatory pathway for approval will likely involve extensive clinical trials to demonstrate safety and efficacy.
DelveInsight's Phosphodiesterase-4 (PDE4) Inhibitor Market Insights report includes a comprehensive understanding of current treatment practices, emerging Phosphodiesterase-4…
Atopic Dermatitis Drugs Market Analysis By Drug Type - Corticosteroids, PDE4 Inh …
Global Atopic Dermatitis Market: Description
Atopic dermatitis is the type of eczema; patients who are suffering with this disease have super sensitive skin and a less threshold for irritation.
Atopic dermatitis consists of hay fever, allergic asthma, atopic dermatitis, food allergies and anaphylaxis.
The rapid development of novel pipeline drugs is expected to accelerate the market growth in the forecast period.
Likewise, the rise in demand for new biologics and product approvals are also…
Biologics Drugs and PDE4 Inhibitors Account for Major Chunk of Atopic Dermatitis …
250 Pages Atopic Dermatitis Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider
According to Fact MR’s recent market research, sales of Atopic Dermatitis to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges.
Focus on…
Biologics Drugs and PDE4 Inhibitors Account for Major Chunk of Atopic Dermatitis …
Global atopic dermatitis market is poised for astounding growth at approximately 24.1% CAGR during the projection period (2020-2027). Millions of people continue to be affected by debilitating skin ailments which in turn escalates the development of new pharmaceutical drugs. Fact.MR projects the revenue pool of atopic dermatitis market to exceed US$ 19 Bn by 2027 end.
“Growing prevalence of dermatological disorders is contributing to the growth of atopic dermatitis market. Manufacturers…
